Clinical Trial: Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta
Study Status: Completed
Recruit Status: RECRUITING
Condition: Osteogenesis Imperfecta
Study Type: INTERVENTIONAL
Official Title: An Open-label, Randomized, Active-Controlled, Phase 3 Study of Setrusumab Compared With Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta Types I, III or IV
Brief Summary:
The primary objective of the study is to evaluate the effect of setrusumab vs intravenous bisphosphonates (IV-BP) on reduction in fracture rate, including morphometric vertebral fractures in pediatric participants.
Read more